Al Ahly Pharos

Pre-Session Views

Al Ahly Pharos
  • Strategy | We are buyers of every dip in Memphis PharmaWe are buyers of every dip in Memphis Pharma
  • RAYA/RACC | RAYA/RACC acquisition is now most likely to go through at RAYA’s revised price of EGP9.0/share, exactly at the midpoint of our previously communicated price range
  • PHAR | EIPICO III delay extends visibility gap, rotation toward MPCI and RMDA
  • AMOC | Shareholder rotation reflects profitability headwinds
  • EGAL | Riding the aluminum wave